Announcement on Voluntary Disclosure of Obtaining Relevant Certifications for the Company's Products
Securities code: 688317 Securities abbreviation: Zhijiang Biotechnology Announcement number: 2026-035
Shanghai Zhijiang Biotechnology Co., Ltd.
Announcement on Voluntary Disclosure of the Company's Products Obtaining Relevant Certifications
The company's board of directors and all directors guarantee that the announcement does not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.
Two products of Shanghai Zhijiang Biotechnology Co., Ltd. (hereinafter referred to as the "Company") have recently obtained relevant certifications. The details are now announced as follows:
1. Relevant certification status
Product name Certification agency Certificate number Application field Validity period
HBV Quantitative Real Time
PCR Kit Vietnam Health 2601983ĐKLH/H Hepatitis B Disease
Long-term hepatitis B virus nucleic acid detection kit part TTB-ĐKKD virus nucleic acid detection
(fluorescence PCR method)
High-Risk Human
Papillomavirus (HPV) and
Genotyping 16 & 18
High-risk human milk
Diagnostic Kit (PCR- Vietnam Health 2602438ĐKLH/H
Head tumor virus core Long-term Fluorescence) Department TTB-ĐKKD
Acid detection
High-risk human papillomavirus (HPV)
Nucleic acid detection and 16&18 typing kit
(fluorescence PCR method)
2. Product details
Use Company Name Product Name Intended Use
scope
HBV Quantitative Real is used to detect hepatitis B in human serum or plasma. Zhijiang Sheng, Shanghai, Vietnam
Time PCR Kit Hepatitis B Virus, and Hepatitis B Virus
Hepatitis B virus nucleic acid detection test (HBV) DNA for in vitro fluorescence PCR quantification Ke Yue Co., Ltd.
Kit (Fluorescent PCR method) Test South Certified National High-Risk Human For use on female cervical exfoliated cells and male
Papillomavirus (HPV) Human papillomavirus in genital secretions
Vietnam and Genotyping 16 & 18 (Human Papillomavirus, HPV)
and recognized Shanghai Jiangsheng Diagnostic Kit (PCR-type 16, type 18, type 31, type 33, type 35
Fluorescence) type, type 39, type 45, type 51, type 52,
Nanjing Co., Ltd. High-risk human papillomavirus type 56, type 58, type 59, type 66, type 68
Certified (HPV) nucleic acid detection and 14 types of specific nucleic acid tablets for types 16&18
National typing kit (fluorescent PCR segment for qualitative detection of fluorescent PCR, and
Method) Current HPV type 16 and 18 typing testing.
3. Impact on the company
After the company's above-mentioned products are certified, they can be sold in Vietnam and countries that recognize Vietnam certification, which further enhances the company's international competitiveness and plays a positive role in the company's expansion of overseas sales product categories and international business expansion.
4. Risk warning
- Product competition risks
In addition to the company's products obtaining relevant certifications, similar products from other companies are also supplied to the market, and the company's products may face market competition risks.
- Uncertain risks in the impact on profits
Affected by various factors such as market competition, the company's product competitiveness and channel capabilities, and customer recognition, the sales and profit contribution of the above products are highly uncertain. There is uncertainty about the impact of the market revenue of the above products on the company's overall revenue.
Investors are kindly requested to pay attention to investment risks.
Announcement is hereby made.
Board of Directors of Shanghai Zhijiang Biotechnology Co., Ltd. July 21, 2026